# Preoperative Marking of the Oral Resection Margin in Esophageal Cancer With a Surgical Fiducial Marker - First Experiences

> **NCT05069766** · NA · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 10 (actual)

## Conditions studied

- Esophagus Cancer, Adenocarcinoma

## Interventions

- **OTHER:** BioXmark™

## Key facts

- **NCT ID:** NCT05069766
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-01
- **Primary completion:** 2022-06-01
- **Final completion:** 2022-06-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2024-02-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05069766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05069766, "Preoperative Marking of the Oral Resection Margin in Esophageal Cancer With a Surgical Fiducial Marker - First Experiences". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05069766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*